Observational Study Evaluating Rituximab Use and Use of the Patient Alert Card in Participants Receiving Rituximab Infusion for a Non-Oncology Indication at Infusion Centers in Europe

NCT02654379 · clinicaltrials.gov ↗

COMPLETED

Status

1408

Enrollment

INDUSTRY

Sponsor class

Conditions

Off-Label Use

Interventions

BIOLOGICAL: Rituximab

Sponsor

Hoffmann-La Roche